Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Biospace

Published November 16, 2026 · Updated November 17, 2026

Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of ...

Read the full story at Biospace

Psychedelics · HHS pumps up to $25M into ibogaine, other psychotropic drugs on Veteran's Day. November 13, 2026. ·. 3 min read. ·. Heather McKenzie.

Surfaced by this Google Alert

  • Psychedelics europe